|
GB202015836D0
|
|
Compositions
|
|
WO2021032807A1
|
|
Combination of a chemotherapeutic agent and alpha-lactoglubulin-oleic acid complex for cancer therapy
|
|
GB202004013D0
|
|
Therapy
|
|
GB201911948D0
|
|
Therapy
|
|
WO2019243547A1
|
|
Therapeutically active complexes
|
|
GB201810108D0
|
|
Therapeutically active complexes
|
|
GB201809965D0
|
|
Therapeutically active complexes
|
|
GB201707715D0
|
|
Preperation of biologically active complexes
|
|
GB201621752D0
|
|
Therapeutically active complexes
|
|
US2015216945A1
|
|
Prophylactic and nutraceutical therapy
|
|
GB201305073D0
|
|
Therapeutic means
|
|
GB201214237D0
|
|
Novel therapeutic composition
|
|
GB201214234D0
|
|
Prophylactic therapy
|
|
GB201211286D0
|
|
Novel biological factor
|
|
HUE031912T2
|
|
Biologically active complex and its preparation
|
|
GB201019936D0
|
|
Therapeutic method
|
|
GB201019938D0
|
|
Determination of therapeutic agents
|
|
GB201019937D0
|
|
Biologically active complex and its preparation
|
|
GB0906199D0
|
|
Complex and production process
|
|
GB0518720D0
|
|
Therapeutic combination
|
